CLOs on the Move

Surgery Partners

www.surgerypartners.com

 
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Spencer Clark
 SVP and General Counsel Profile
Roxanne Womack
 SVP, Chief Compliance Officer Profile
Spencer Clark
 VP and Senior Legal Counsel Profile
Kelly Whelan
 VP and Senior Legal Counsel, American and Eastern Groups Profile

Similar Companies

Lutheran Home Care and Hospice

Lutheran Home Care & Hospice is a Chambersburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jacobi Medical Center

Jacobi Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Jacobi Medical Center is based in Bronx, NY. You can find more information on Jacobi Medical Center at www.nbhn.net

Oceana Therapeutics

Oceana Therapeutics is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Great Lakes Health Plan

Great Lakes Health Plan, Inc. is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III